Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Mise à jour : Il y a 4 ans
Référence : NCT00562237

Femme et Homme

Extrait

Several combinations of H5N1 antigen concentrations and aluminium-hydroxide adjuvant concentrations will be tested for their safety and capacity to induce a specific immune response.


Critère d'inclusion

  • Healthy subjects

Liens